FAILDEX失樂園
中文

JournalSpace

The business, the turning points, and the decisions behind them.

Founded2002
Event year2009

01 / WHAT IT BUILT

What the company did

JournalSpace was an online blogging community founded in 2002, owned by half-brothers Dylan and Holland Rhodes through their company Lagomorphics. Over nearly six years it built a community of bloggers and a significant repository of user data — blogs, journals and entries hosted on its servers. On December 18, 2008 the entire database was wiped by a disgruntled former IT employee; the mirrored drives simply cloned the deletion, and no backup existed, so the data was unrecoverable and the service shut down.

02 / JournalSpace FAILURE REASONS

Failure factors supported by the current evidence

JournalSpace's production database was overwritten in a malicious act by a disgruntled former employee, and the company had no usable backup.

Operations

The production database was maliciously overwritten and no usable backup existed.

03 / EVENT HISTORY

Events in the structured record

  1. Operations ended

    JournalSpace ceased operating after losing its production database.

04 / CONTEMPORARY REBUILD ASSESSMENT

Difficulty of rebuilding this project today

Material for this section is being gathered and checked. It will appear here once ready.

Rebuild difficultyPending assessmentNot completed
Scoring basisNot completed
ScalabilityPending assessmentNot completed
Scoring basisNot completed

Overall assessment: Not completed

05 / CAUSAL CHAIN

How the factors connect

  1. 01

    On December 18, 2008 the JournalSpace data server was wiped; administrators discovered the RAID mirror had cloned the deletion and no usable backup existed.

  2. 02

    Drives were sent to DriveSavers on December 22, but the data was declared unrecoverable; 'the data was simply gone. Overwritten.'

  3. 03

    The company announced 'after nearly six years, journalspace is no more,' released no further product, and listed the JournalSpace.com and .net domains for sale on eBay, pledging 15% of the sale price to Susan G. Komen for the Cure.